Intravenous Ketamine as an Adjunct for Pachyonychia Congenita-Associated Pain: A Case Report.
A A Pract
; 13(8): 319-321, 2019 Oct 15.
Article
em En
| MEDLINE
| ID: mdl-31343433
ABSTRACT
Pachyonychia congenita (PC) is a rare, inherited disorder of keratin filaments characterized by palmoplantar hyperkeratosis, keratoderma, and extreme pain. Management is largely symptomatic and typically involves multimodal pain control strategies. Here, we report the treatment of one 21-year-old man's refractory neuropathic PC pain with a 4-day inpatient ketamine infusion. Within 1 night of beginning treatment, his pain diminished to a 0/10 without any adverse effects, with effects lasting 2 weeks. No reported PC pain regimens have made use of intravenous ketamine; thus, we suggest recurrent ketamine infusions as an additional option in the multimodal pain regimen for patients with PC.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Paquioníquia Congênita
/
Analgésicos
/
Ketamina
/
Neuralgia
Tipo de estudo:
Risk_factors_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
A A Pract
Ano de publicação:
2019
Tipo de documento:
Article